Template:Short description Template:Main other <templatestyles src="Infobox drug/styles.css"/> {{#invoke:Infobox|infobox}}Template:Template other{{#invoke:TemplatePar |check |template=Template:Infobox_drug |all= |opt= pronounce= pronounce_ref= pronounce_comment= ATC_prefix= ATC_suffix= ATC_supplemental= ATCvet= biosimilars= CAS_number_Ref= CAS_number= CAS_supplemental= ChEBI= ChEBI_Ref= ChEMBL_Ref= ChEMBL= ChemSpiderID= ChemSpiderID_Ref= chirality= class= container_only= DailyMedID= data_page= DrugBank_Ref= DrugBank= Drugs.com= duration_of_action= INN= INN_EMA= IUPAC_name= IUPHAR_ligand= KEGG_Ref= KEGG= MedlinePlus= NIAID_ChemDB= PDB_ligand= PubChemSubstance= PubChem= StdInChIKey_Ref= StdInChIKey= StdInChI_Ref= StdInChI_comment= StdInChI= UNII_Ref= UNII= DTXSID= Verifiedfields= Watchedfields= addiction_liability= alt2= altL= altR= alt= bioavailability= boiling_high= boiling_notes= boiling_point= captionLR= caption= caption2= charge= chemical_formula= chemical_formula_ref= chemical_formula_comment= class1= class2= class3= class4= class5= class6= component1= component2= component3= component4= component5= component6= density= density_notes= dependency_liability= drug_name= elimination_half-life= engvar= excretion= image2= imageL= imageR= image= image_class= image_class2= image_classL= image_classR= Jmol= legal_AU= legal_BR= legal_CA= legal_DE= legal_EU= legal_NZ= legal_UK= legal_UN= legal_US= legal_AU_comment= legal_BR_comment= legal_CA_comment= legal_DE_comment= legal_UK_comment= legal_NZ_comment= legal_US_comment= legal_UN_comment= legal_EU_comment= legal_status= licence_CA= licence_EU= licence_US= license_CA= license_EU= license_US= mab_type= melting_high= melting_notes= melting_point= metabolism= metabolites= molecular_weight= molecular_weight_round= molecular_weight_unit= molecular_weight_ref= molecular_weight_comment= onset= pregnancy_AU= pregnancy_AU_comment= pregnancy_category= protein_bound= routes_of_administration= SMILES= smiles= solubility= sol_units= source= specific_rotation= synonyms= target= tradename= type= vaccine_type= verifiedrevid= width2= widthL= widthR= width= AAN= BAN= JAN= USAN= source_tissues= target_tissues= receptors= agonists= antagonists= precursor= biosynthesis= gt_target_gene= gt_vector= gt_nucleic_acid_type= gt_editing_method= gt_delivery_method= sec_combustion= Ac=Ag=Al=Am=Ar=As=At=Au=B=Ba=Be=Bh=Bi=Bk=Br=C=Ca=Cd=Ce=Cf=Cl=Cm=Cn=Co=Cr=Cs=Cu= D=Db=Ds=Dy=Er=Es=Eu=F=Fe=Fl=Fm=Fr=Ga=Gd=Ge=H=He=Hf=Hg=Ho=Hs=I=In=Ir=K=Kr=La=Li=Lr=Lu=Lv= Mc=Md=Mg=Mn=Mo=Mt=N=Na=Nb=Nd=Ne=Nh=Ni=No=Np=O=Og=Os=P=Pa=Pb=Pd=Pm=Po=Pr=Pt=Pu=Ra=Rb=Re=Rf=Rg=Rh=Rn=Ru=S=Sb=Sc=Se=Sg=Si=Sm=Sn=Sr=Ta=Tb=Tc=Te=Th=Ti=Tl=Tm=Ts=U=V=W=Xe=Y=Yb=Zn=Zr= index_label= index2_label= index_comment= index2_comment= CAS_number2= CAS_supplemental2= ATC_prefix2= ATC_suffix2= ATC_supplemental2= PubChem2= PubChemSubstance2= IUPHAR_ligand2= DrugBank2= ChemSpiderID2= UNII2= KEGG2= ChEBI2= ChEMBL2= PDB_ligand2= NIAID_ChemDB2= SMILES2= smiles2= StdInChI2= StdInChIKey2= CAS_number2_Ref= ChEBI2_Ref= ChEMBL2_Ref= ChemSpiderID2_Ref= DrugBank2_Ref= KEGG2_Ref= StdInChI2_Ref= StdInChIKey2_Ref= UNII2_Ref= DTXSID2= QID= QID2=PLLR= pregnancy_US= pregnancy_US_comment= |cat=Pages using infobox drug with unknown parameters |format=0|errNS=0

|preview=

@@@ (See parameter list). This message only shows in Preview, it will not show after you do Template:Button.

}}{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =

| _has_physiological_data= | _has_gene_therapy=

| vaccine_type= | mab_type= | _number_of_combo_chemicals={{#invoke:ParameterCount |main |component1 |component2 |component3 |component4|component5|component6 }} | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=3251FC(F)(F)C(Cl)OC(F)F1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2HPIWKPBJCKXDKJR-UHFFFAOYSA-NTemplate:StdinchiciteTemplate:Stdinchicite | _combo_data= | _physiological_data= | _clinical_data=Template:Drugs.comIsoflurane <ref name="Drugs.com pregnancy">{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>B3InhalationForane, othersN01 | _legal_data=<ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>C1<ref name="Isoflurane SmPC">{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>POM<ref name="Forane FDA label">{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>Rx-only

| _other_data=(RS)-2-Chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane
OR
(RS)-1-chloro-2,2,2-trifluoroethyl difluoromethyl ether

| _image_0_or_2 = Isoflurane.svgIsoflurane-3D-vdW.png | _image_LR =

| _datapage = Isoflurane (data page) | _vaccine_target={{#ifeq: | vaccine | | _type_not_vaccine }} | _legal_all=C1POMRx-only | _ATC_prefix_supplemental=N01 | _has_EMA_link = | CAS_number=26675-46-7 | PubChem=3763 | ChemSpiderID=3631 | ChEBI=6015 | ChEMBL=1256 | DrugBank=DB00753 | KEGG=D00545 | _hasInChI_or_Key={{#if:1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2HPIWKPBJCKXDKJR-UHFFFAOYSA-N |yes}} | UNII=CYS9AKD70P | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =

| _countSecondIDs={{#invoke:ParameterCount |main |CAS_number2 |ATC_prefix2 |PubChem2 |PubChemStructure2 |IUPHAR_ligand2 |DrugBank2 |ChemSpiderID2 |UNII2 |KEGG2 |ChEBI2 |ChEMBL2 |PDB_ligand2 |NIAID_ChemDB2 |SMILES2 |smiles2 |StdInChI2 |StdInChIKey2 |DTXCID2}} | _countIndexlabels={{#invoke:ParameterCount |main |index_label |index2_label}} | _trackListSortletter= |QID = |QID2 = |Verifiedfields=changed |Watchedfields=changed |verifiedrevid=443883276}}

Isoflurane, sold under the brand name Forane among others, is a general anesthetic.<ref name="Forane FDA label" /> It can be used to start or maintain anesthesia; however, other medications are often used to start anesthesia, due to airway irritation with isoflurane.<ref name="Isoflurane SmPC" /><ref>Template:Cite book</ref> Isoflurane is given via inhalation.<ref name="Forane FDA label" />

Side effects of isoflurane include a decreased ability to breathe (respiratory depression), low blood pressure, and an irregular heartbeat.<ref name="Isoflurane SmPC" /> Serious side effects can include malignant hyperthermia or high blood potassium.<ref name="Forane FDA label" /> It should not be used in patients with a history of malignant hyperthermia in either themselves or their family members.<ref name="Isoflurane SmPC" /> It is unknown if its use during pregnancy is safe for the fetus, but use during a cesarean section appears to be safe.<ref name="Isoflurane SmPC" /><ref name="Forane FDA label" /> Isoflurane is a halogenated ether.<ref>Template:Cite book</ref>

Isoflurane was approved for medical use in the United States in 1979.<ref name="Forane FDA label" /><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> It is on the World Health Organization's List of Essential Medicines.<ref name="WHO21st">Template:Cite book</ref><ref name="WHO22nd">Template:Cite book</ref>

Medical usesEdit

Isoflurane is always administered in conjunction with air or pure oxygen. Often, nitrous oxide is also used. Although its physical properties imply that anaesthesia can be induced more rapidly than with halothane,<ref name="NiedermeyerSilva2005">Template:Cite book</ref> its pungency can irritate the respiratory system, negating any possible advantage conferred by its physical properties. Thus, it is mostly used in general anesthesia as a maintenance agent after induction of general anesthesia with an intravenous agent such as thiopentone or propofol.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref name = NBK532957>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

Mechanism of actionEdit

Similar to many general anesthetics, the exact mechanism of the action has not been clearly delineated.<ref>Template:Cite magazine</ref> Isoflurane reduces pain sensitivity (analgesia) and relaxes muscles. Isoflurane likely binds to GABA, glutamate and glycine receptors, but has different effects on each receptor. Isoflurane acts as a positive allosteric modulator of the GABAA receptor in electrophysiology studies of neurons and recombinant receptors.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> It potentiates glycine receptor activity, which decreases motor function.<ref>Template:Cite journal</ref> It inhibits receptor activity in the NMDA glutamate receptor subtypes. Isoflurane inhibits conduction in activated potassium channels.<ref>Template:Cite journal</ref> Isoflurane also affects intracellular molecules. It inhibits plasma membrane calcium ATPases (PMCAs) which affects membrane fluidity by hindering the flow of Ca2+ (calcium ions) out across the membrane, this in turn affects neuron depolarization.<ref>Template:Cite journal</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref> It binds to the D subunit of ATP synthase and NADH dehydrogenase.

General anaesthesia with isoflurane reduces plasma endocannabinoid AEA concentrations, and this could be a consequence of stress reduction after loss of consciousness.<ref>Template:Cite journal</ref>

Adverse effectsEdit

Isoflurane can cause a sudden decrease in blood pressure due to dose-dependent peripheral vasodilation. This may be specially marked in hypovolemic patients.<ref name = NBK532957/>

Animal studies have raised safety concerns of certain general anesthetics, in particular ketamine and isoflurane, in young children. The risk of neurodegeneration was increased in combination of these agents with nitrous oxide and benzodiazepines such as midazolam.<ref name=Mel2007>Template:Cite journal</ref> Whether these concerns occur in humans is unclear.<ref name=Mel2007/>

ElderlyEdit

Biophysical studies using NMR spectroscopy has provided molecular details of how inhaled anesthetics interact with three amino acid residues (G29, A30 and I31) of amyloid beta peptide and induce aggregation.<ref name="Mandal-2009">Template:Cite journal</ref> This area is important as "some of the commonly used inhaled anesthetics may cause brain damage that accelerates the onset of Alzheimer's disease".<ref name="Kuehn-2007">Template:Cite journal</ref>

Physical propertiesEdit

Molecular weight 184.5g/mol<ref name=":0">{{#invoke:citation/CS1|citation CitationClass=web

}}</ref>||

Boiling point (at 1 atm): 48.5 °C<ref name=":0" />
Density (at 25 °C): 1.496 g/mL<ref name=":0" />
MAC : 1.15 vol %
Vapor pressure: 238 mmHg 31.7 kPa (at 20 °C)
295 mmHg 39.3 kPa (at 25 °C)
367 mmHg 48.9 kPa (at 30 °C)
450 mmHg 60.0 kPa (at 35 °C)<ref name=":0" />
Water solubility 13.5 mM (at 25 °C)<ref>Template:Cite journal</ref>
Blood:gas partition coefficient: 1.4
Oil:gas partition coefficient: 98

It is administered as a racemic mixture of (R)- and (S)-optical isomers.<ref>Template:Cite journal</ref> Isoflurane has a boiling point of Template:Convert.<ref name=":0" /> It is non-combustible but can give off irritable and toxic fumes when exposed to flame.<ref name=":0" />

HistoryEdit

Together with enflurane and halothane, Isoflurane began to replace the flammable ethers used in the pioneer days of surgery; this shift began in the 1940s to the 1950s.<ref>Template:Cite journal</ref> Its name comes from being a structural isomer of enflurane, hence they have the same empirical formula.<ref>Template:Cite journal</ref>

EnvironmentEdit

The average lifetime of isoflurane in the atmosphere is 3.2 years, its global warming potential is 510 and the yearly emissions add up to 880 tons.<ref>Template:Cite journal</ref>

Veterinary useEdit

Isoflurane is frequently used for veterinary anaesthesia.<ref>Template:Cite journal</ref><ref>{{#invoke:citation/CS1|citation |CitationClass=web }}</ref>

ReferencesEdit

Template:Reflist

External linksEdit

  • {{#invoke:citation/CS1|citation

|CitationClass=web }}

  • {{#if:3535388

|[{{#ifeq:|uspto|http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=%7Chttps://patents.google.com/patent/US}}{{#iferror:{{#expr:3535388 }}|3535388}} U.S. patent {{#ifeq:Template:Replace|Template:Digits|Template:Replace|3535388}}] |{{US patent|123456|link text}}}} - 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether

  • {{#if:3535425

|[{{#ifeq:|uspto|http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=%7Chttps://patents.google.com/patent/US}}{{#iferror:{{#expr:3535425 }}|3535425}} U.S. patent {{#ifeq:Template:Replace|Template:Digits|Template:Replace|3535425}}] |{{US patent|123456|link text}}}} - 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether as an anesthetic agent

Template:General anesthetics Template:Navboxes Template:Portal bar